JYJunkai Yao

Junkai Yao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Junkai Yao has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Gamabufotalin Improves Cardiac Remodeling in LADL/ISO-Induced Heart Failure Animal Models by Targeting TGFBR1 to Regulate Smad2/3 Nuclear Translocation

    by Junkai Yao, Yunfeng Di, Chao Yong Wu, Lu Zhou, Mingyan Shao, Yong Wang, Wei Wang

    Background: Gamabufotalin (Ga) is a primary bioactive bufadienolide extracted from Venenum Bufonis. It has been identified to exert anti-fibrotic and anti-inflammatory properties; however, its anti-fibrotic effect and underlying mechanism in heart failure (HF) remain undetermined.Purpose: This study aimed to evaluate the cardioprotective and anti-fibrotic properties of Ga in LADL-induced HF rats and isoproterenol (ISO)-induced HF mice. Furthermore, the molecular target and signaling mechanisms associated with Ga were investigated.Methods: In vivo cardiac function and fibrosis rate were assessed by echocardiography, histopathology, and Western blotting. For in vitro analysis, primary cardiac fibroblasts (CFs) were first stimulated with TGF-β1 and then evaluated for proliferation and migration using CCK-8, EdU, wound healing, and Transwell assays. Molecular docking and rescue assays were carried out using the TGFBR1 agonist SRI. Moreover, a Smad2/3 nuclear translocation assay was performed to identify the key target and mechanism.Results: The data revealed that Ga significantly improved cardiac function, alleviated myocardial hypertrophy and fibrosis, and inhibited activation of TGFBR1/Smad signaling in two HF models. In vitro, Ga (20 nM) inhibited TGF-β1-induced CF proliferation and migration, decreased Smad2/3 phosphorylation and nuclear translocation, and downregulated fibrotic markers. Ga directly targeted TGFBR1, whereas its anti-fibrotic effects were reversed by SRI-mediated TGFBR1 activation.Conclusion: This study revealed that Ga alleviates myocardial fibrosis and improves heart function by directly suppressing TGFBR1 and blocking downstream Smad2/3 signaling. These results suggest that Ga could serve as an anti-fibrotic agent for HF and provide pharmacological evidence for the modern application of toad venom–derived compounds.

  • Open Access

    TCMCard: A High-Confidence Digital Infrastructure for Traditional Chinese Medicine Quantified by Multi-Dimensional Evidence Integration

    by Yuqi Wang, Wenqing Dong, Junkai Yao, Kai Wang, Leyuan Zhang, Yuanrong Wang, Shanshan Guo, Haorui Li, Hengjia Cai, Xiting Wang, et al.

    Network pharmacology has become a widely used approach for deciphering multi-component, multi-target mechanisms of traditional Chinese medicine (TCM). Here we introduce TCMCard, a high-confidence digital infrastructure built on a Multi-Dimensional Evidence Integration (MDEI) framework. The framework integrates experimental activity data from authoritative chemical databases, literature-derived evidence, and structure-based similarity inference. Preprocessing steps include chemical structure normalization, species-specific filtering, and target quality scoring. Applied to conventional interaction datasets, this pipeline leads to the removal of over 60% of low-confidence noise. TCMCard supports network pharmacology exploration through an interactive visualization platform, and module analysis identifies functionally relevant communities that offer insights into the synergistic actions of TCM formulas. Overall, TCMCard may help move the field beyond simple data aggregation toward evidence-informed curation and quality-driven analysis. As an interactive and publicly accessible platform, it reveals an organized backbone within complex interaction networks, offering a more reliable basis for understanding multi-component synergy in TCM.